SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 28, 2021
(Exact name of registrant as specified in its charter)
|Minnesota|| ||0-7647|| ||41-0771293|
|(State of Incorporation)|| ||(Commission File Number)|| ||(IRS Employer Identification No.)|
|(Address of Principal Executive Offices)||(Zip Code)|
Registrant’s Telephone Number, Including Area Code (612) 331-6910
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which registered
Common Stock, par value $.05 per share
Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b 2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02. Results of Operations and Financial Condition.
On January 28, 2021, Hawkins, Inc. issued a press release announcing financial results for its fiscal 2021 third quarter ended December 27, 2020. A copy of the press release issued by the Registrant is furnished herewith as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
|Exhibit No.|| ||Description|| ||Method of Filing|
Press Release, dated January 28, 2021, announcing financial results of Hawkins, Inc. for its fiscal 2021 third quarter ended December 27, 2020.
| ||Filed Electronically|
|104 ||Cover Page Interactive Data File (embedded within the inline XBRL document)||Filed Electronically|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ||HAWKINS, INC.|
Date: January 28, 2021
| ||By:|| ||/s/ Jeffrey P. Oldenkamp |
| || ||Jeffrey P. Oldenkamp |
| || ||Executive Vice President and Chief Financial Officer|
|FOR IMMEDIATE RELEASE|
|January 28, 2021|
|Roseville, MN 55113|
HAWKINS, INC. REPORTS
THIRD QUARTER FISCAL 2021 RESULTS
Minneapolis, MN, January 28, 2021 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three and nine months ended December 27, 2020, its third quarter of fiscal 2021. Highlights include:
•Record third quarter sales of $142.9 million, a 19% year-over-year increase, with a 75% year-over-year sales increase in our Health and Nutrition segment.
•Record third quarter gross profit of $28.2 million, a 31% increase over the prior year, contributing to a 55% year-over-year increase in operating income.
•Third quarter diluted earnings per share (EPS) of $0.75, which was $0.32, or 74%, higher than the same period last year.
•Year to date diluted EPS of $3.00, a 35% increase over the prior year.
•Net debt of $88 million and a leverage ratio of 1.2x, while reinitiating stock repurchases in the third quarter.
•Extended our Water Treatment footprint into Louisiana through the acquisition of C & L Aqua Professionals, Inc. and LC Blending, Inc. on December 30, 2020.
Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:
“We are very pleased with our company’s continued growth in net income this quarter. We have continued to operate and execute on our business strategy throughout this pandemic, and our business segment operating results reflected substantial year-over-year improvement in the third quarter. In particular, our Health and Nutrition segment reported revenue growth of 75% over the same period last year, with operating income growing to nearly six times the levels of last year due to increased demand for health and immunity products. In our Water Treatment segment, our acquisition of American Development Corporation has been accretive, and while we've seen some areas of softness in our legacy business, which we believe is related to COVID-19 impacts, increased sales of our specialty and manufactured products contributed to the year-over-year increase. Our Industrial segment reported year-over-year sales growth in the third quarter for the first time this year, with gross profit increasing nearly 10% as a result of increased sales of our specialty and manufactured products."
Mr. Hawkins continued, "As previously announced, we extended our Water Treatment footprint into the state of Louisiana with acquisitions at the end of December, and look forward to continuing to grow our business as a result. In addition, we acquired a manufacturing facility to allow further expansion and growth in both our Industrial and Water Treatment segments. This site is adjacent to our facility in Rosemount, Minnesota, adding 40,000 square feet of manufacturing and warehouse space on 28 acres of land to bring us to a total of 105,000 square feet of space on 56 acres of land in that area, with rail access at both of the sites to allow for future growth and provide for supply chain flexibility on certain raw materials to better serve our customers. These actions reaffirm our deep commitment to continue to grow the business.”
Third Quarter Financial Highlights:
Sales were $142.9 million for the third quarter of fiscal 2021, an increase of 19%, from sales of $120.4 million for the same period of the prior year. Industrial segment sales increased $1.4 million, or 2%, to $64.4 million for the current quarter, as compared to $63.0 million for the same period of the prior year. The increase in sales dollars from the prior year was driven largely by a product mix shift of more sales of certain of our higher-priced manufactured, blended and repackaged products. Water Treatment segment sales increased $4.4 million, or 13%, to $39.3 million for the current quarter, as compared to $34.9 million for the same period of the prior year. The increase in sales dollars from the prior year was largely attributable to added sales from the acquisition of ADC. Sales by our legacy business also increased overall due to increased sales of our manufactured, blended and repackaged products. Sales for our Health and Nutrition segment increased $16.8 million, or 75%, to $39.3 million for the current quarter, as compared to $22.5 million for the same period of the prior year. The increase in sales was driven by increased sales of both our manufactured and specialty distributed products largely as a result of increased consumer demand for health and immunity products.
Gross profit increased $6.7 million, or 31%, to $28.2 million, or 20% of sales, for the current quarter, from $21.5 million, or 18% of sales, for the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profits
decreased, by $0.1 million. In the same quarter a year ago, the LIFO reserve decreased, and gross profits increased, by $0.3 million. Gross profit for the Industrial segment increased $0.8 million, or 9%, to $9.2 million, or 14% of sales, for the current quarter, from $8.4 million, or 13% of sales, for the same period of the prior year. Total Industrial segment gross profit, and gross profit as a percentage of sales, increased due to a product mix shift to more sales of certain higher-margin manufactured, blended and re-packaged products. Gross profit for the Water Treatment segment increased $1.6 million to $10.0 million, or 26% of sales, for the current quarter, from $8.4 million, or 24% of sales, for the same period of the prior year. Gross profit in our Water Treatment segment increased as a result of the added gross profit from the sales in the acquired ADC business, as well as increased sales of manufactured, blended and repackaged products in our legacy business. Gross profit for our Health and Nutrition segment increased $4.3 million, or 92%, to $9.0 million, or 23% of sales, for the current quarter, from $4.7 million, or 21% of sales, for the same period of the prior year. Gross profit in our Health and Nutrition segment increased as a result of higher sales compared to the prior year.
Company-wide selling, general and administrative expenses increased $3.1 million to $17.8 million, or 12% of sales, for the current quarter, compared to $14.7 million, or 12% of sales, for the same period of the prior year. Expenses increased primarily due to an increase in variable costs, primarily variable compensation, added costs from the acquired ADC business, including amortization of intangibles, and acquisition expenses. In addition, we recorded a year-over-year expense increase of $0.3 million due to higher compensation expense relating to the non-qualified deferred compensation plan liability which is offset in other income as described below. These increases were partially offset by a decrease in travel and trade show expenses due to restrictions imposed as a result of COVID-19.
Our effective income tax rate was 25.2% for the current quarter, compared to 28.1% in the same period of the prior year. The effective tax rate decreased from the prior year due to favorable tax provision adjustments recorded in the third quarter of fiscal 2021. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes.
Earnings before interest, taxes, depreciation and amortization ("EBITDA"), a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of EBITDA is presented below. EBITDA for the three months ended December 27, 2020 was $17.8 million, an increase of $4.8 million, or 37%, from EBITDA of $13.0 million for the same period of the prior year. The increase was primarily due to improved gross profit.
About Hawkins, Inc.
Hawkins, Inc. was founded in 1938 and is a leading specialty chemical company that distributes, blends and manufactures chemicals and other specialty ingredients for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, and with 46 facilities in 21 states, the Company creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $540 million of revenue in fiscal 2020 and has approximately 700 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.
Reconciliation of Non-GAAP Financial Measures
We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.
Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.
We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.
|Adjusted EBITDA||Three Months Ended||Nine months ended|
|(In thousands)||December 27, 2020||December 29, 2019||December 27, 2020||December 29, 2019|
|Net Income (GAAP)||$||7,921 ||$||4,547 ||$||31,899 ||$||23,604 |
|Interest expense, net||382 ||584 ||1,101 ||2,013 |
|Income tax expense||2,664 ||1,776 ||11,285 ||8,571 |
|Amortization of intangibles||1,521 ||1,268 ||4,237 ||3,805 |
|Depreciation expense||4,149 ||4,174 ||12,498 ||12,376 |
|Non-cash compensation expense||917 ||685 ||2,303 ||1,830 |
|Non-recurring acquisition expenses ||243 ||— ||508 ||— |
|Adjusted EBITDA||$||17,797 ||$||13,034 ||$||63,831 ||$||52,199 |
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)
|Three Months Ended||Nine Months Ended|
|December 27, 2020||December 29, 2019||December 27, 2020||December 29, 2019|
|Sales||$||142,927 ||$||120,406 ||$||433,900 ||$||407,785 |
|Cost of sales||(114,688)||(98,928)||(341,888)||(329,516)|
|Gross profit||28,239 ||21,478 ||92,012 ||78,269 |
|Selling, general and administrative expenses||(17,750)||(14,702)||(49,009)||(44,355)|
|Operating income||10,489 ||6,776 ||43,003 ||33,914 |
|Interest expense, net||(382)||(584)||(1,101)||(2,013)|
|Other income||478 ||131 ||1,282 ||274 |
|Income before income taxes||10,585 ||6,323 ||43,184 ||32,175 |
|Income tax expense||(2,664)||(1,776)||(11,285)||(8,571)|
|Net income||$||7,921 ||$||4,547 ||$||31,899 ||$||23,604 |
|Weighted average number of shares outstanding - basic||10,506,918 ||10,546,453 ||10,521,521 ||10,575,432 |
|Weighted average number of shares outstanding - diluted||10,611,655 ||10,605,895 ||10,639,372 ||10,656,115 |
|Basic earnings per share||$||0.75 ||$||0.43 ||$||3.03 ||$||2.23 |
|Diluted earnings per share||$||0.75 ||$||0.43 ||$||3.00 ||$||2.22 |
|Cash dividends declared per common share||$||0.2325 ||$||0.2300 ||$||0.6975 ||$||0.6900 |
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
|Cash and cash equivalents||$||7,969 ||$||4,277 |
|Trade receivables — less allowance for doubtful accounts:|
$549 as of December 27, 2020 and $784 as of March 29, 2020
|76,822 ||67,391 |
|Inventories||64,657 ||54,436 |
|Income taxes receivable||946 ||— |
|Prepaid expenses and other current assets||5,075 ||4,927 |
|Total current assets||155,469 ||131,031 |
|PROPERTY, PLANT, AND EQUIPMENT:||291,491 ||267,221 |
|Less accumulated depreciation||152,568 ||140,877 |
|Net property, plant, and equipment||138,923 ||126,344 |
|Right-of-use assets||8,181 ||9,090 |
|Goodwill||67,657 ||58,440 |
|Intangible assets, net of accumulated amortization||69,726 ||60,653 |
|Other||6,049 ||3,770 |
|Total other assets||151,613 ||131,953 |
|Total assets||$||446,005 ||$||389,328 |
|LIABILITIES AND SHAREHOLDERS’ EQUITY|
|Accounts payable — trade||$||31,160 ||$||34,129 |
|Accrued payroll and employee benefits||13,406 ||13,538 |
|Current portion of long-term debt||9,907 ||9,907 |
|Short-term lease liability||1,440 ||1,523 |
|Container deposits||1,426 ||1,376 |
|Other current liabilities||1,693 ||1,747 |
|Total current liabilities||59,032 ||62,220 |
|LONG-TERM DEBT, LESS CURRENT PORTION||85,821 ||49,751 |
|LONG-TERM LEASE LIABILITY||6,854 ||7,649 |
|PENSION WITHDRAWAL LIABILITY||4,719 ||4,978 |
|DEFERRED INCOME TAXES||25,097 ||25,106 |
|DEFERRED COMPENSATION LIABILITY||7,054 ||5,026 |
|OTHER LONG-TERM LIABILITIES||514 ||1,114 |
|Total liabilities||189,091 ||155,844 |
|COMMITMENTS AND CONTINGENCIES||— ||— |
Common stock; authorized: 30,000,000 shares of $0.05 par value; 10,462,159 and 10,512,229 shares issued and outstanding as of December 27, 2020 and March 29, 2020, respectively
|523 ||526 |
|Additional paid-in capital||48,975 ||50,090 |
|Retained earnings||207,416 ||182,947 |
|Accumulated other comprehensive loss||— ||(79)|
|Total shareholders’ equity||256,914 ||233,484 |
|Total liabilities and shareholders’ equity||$||446,005 ||$||389,328 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| ||Nine Months Ended|
| ||December 27,|
|CASH FLOWS FROM OPERATING ACTIVITIES:|
|Net income||$||31,899 ||$||23,604 |
|Reconciliation to cash flows:|
|Depreciation and amortization||16,735 ||16,181 |
|Operating leases||1,419 ||1,538 |
|Gain on deferred compensation assets||(1,282)||(274)|
|Stock compensation expense||2,303 ||1,830 |
|Changes in operating accounts providing (using) cash:|
|Trade receivables||(8,121)||8,035 |
|Accrued liabilities||1,160 ||(3,148)|
|Net cash provided by operating activities||26,606 ||44,991 |
|CASH FLOWS FROM INVESTING ACTIVITIES:|
|Purchases of property, plant, and equipment||(13,200)||(19,426)|
|Acquisitions, net of cash acquired||(35,017)||— |
|Other ||154 ||326 |
|Net cash used in investing activities||(48,063)||(19,100)|
|CASH FLOWS FROM FINANCING ACTIVITIES:|
|Cash dividends declared and paid||(7,430)||(7,350)|
|New shares issued||773 ||661 |
|Shares surrendered for payroll taxes||(54)||(343)|
|Net proceeds from (payments on) revolving loan||36,000 ||(17,000)|
|Net cash provided by (used in) financing activities||25,149 ||(27,825)|
|NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS||3,692 ||(1,934)|
|CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD||4,277 ||9,199 |
|CASH AND CASH EQUIVALENTS, END OF PERIOD||$||7,969 ||$||7,265 |
|SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION|
|Cash paid for income taxes||$||12,345 ||$||8,653 |
|Cash paid for interest||$||893 ||$||1,960 |
|Noncash investing activities - capital expenditures in accounts payable||$||790 ||$||394 |
Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to impact and duration of wage pressures, the levels of investment and the impact of investments on our business operations and financial condition, the timing of new Water Treatment branch investments, and the duration and impact of product shortages. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, the impact and severity of the COVID-19 outbreak, changes in the labor markets, our available cash for investments, our business capital needs, changes in competition and price pressure, changes in demand and customer requirements or processes for our products, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, our ability to locate suitable real estate for new branch additions, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 29, 2020, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.
Contacts: Jeffrey P. Oldenkamp
Executive Vice President and Chief Financial Officer